• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与肾脏替代疗法相比,保守治疗与更差的临床特征和生化紊乱相关:加纳库马西的一项回顾性研究。

Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana.

机构信息

Department of Medicine, School of Medicine and Dentistry, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

Department of Surgery, School of Medicine and Dentistry, College of Health Sciences, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana.

出版信息

BMC Nephrol. 2022 Oct 26;23(1):343. doi: 10.1186/s12882-022-02951-z.

DOI:10.1186/s12882-022-02951-z
PMID:36289495
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9608926/
Abstract

BACKGROUND

The incidence of end stage kidney disease (ESKD) is increasing in Ghana as with the rest of the world. This study compared the sociodemographic, diagnostic characteristics (clinical, biochemical and imaging) and clinical outcomes of ESKD patients who chose either renal replacement therapy (RRT) or conservative therapy as well as the factors that influenced their choice.

METHODS

We retrospectively reviewed the records of 382 ESKD patient from 2006 to 2018. The data was collected from the Nephrology Clinic at the Komfo Anokye Teaching Hospital (KATH). Sociodemographic, diagnostic (clinical, biochemical and imaging) and therapeutic data were obtained, organized and analyzed with Statistical Package for the Social Sciences (SPSS).

RESULTS

Of the 382 patients, 321 had conservative therapy whiles 61 had renal replacement therapy. The mean age of participants was 47.71 ± 16.10 years. Bipedal swelling (16.8%), fatigue (10.4%) and facial swelling (9.2%) were the major clinical features. Chronic glomerulonephritis (31.4%), hypertension (30.3%) and diabetes mellitus nephropathy (28.2%) were the most frequent predisposing conditions. Nifedipine (82.0%), bisoprolol (32.8%), aspirin (19.7%), ranitidine (26.2%), metformin (13.1%) and lasix (78.7%) were commonly used by the RRT patients than their conservative therapy counterparts. Compared to their RRT counterparts, patients on conservative therapy were more on irbesartan/lisinopril (57.9%) and sodium hydro carbonate (NaHCO) (52.0%). Diastolic blood pressure (DBP) (p = 0.047), uremic gastritis (p = 0.007), anaemia, uraemia, haematuria and hyperkalaemia (p < 0.001) were more common in conservative therapy patients than RRT patients with RRT patients showing better corticomedullary differentiation (38.1% vs. 27.7%, p < 0.001) and normal echotexture (15.0% vs. 11.6%, p = 0.005). Age, gender, occupation and duration of illness were significantly associated with the decision to opt for conservative therapy.

CONCLUSION

Patients on conservative therapy have worse clinical outcomes than their RRT counterparts. Early referrals to nephrologist as well as subsidized RRT should be targeted.

摘要

背景

加纳与世界其他地区一样,终末期肾病 (ESKD) 的发病率正在上升。本研究比较了选择肾脏替代治疗 (RRT) 或保守治疗的 ESKD 患者的社会人口统计学、诊断特征(临床、生化和影像学)和临床结局,以及影响他们选择的因素。

方法

我们回顾性分析了 2006 年至 2018 年期间在 Komfo Anokye 教学医院 (KATH) 肾病科就诊的 382 名 ESKD 患者的记录。收集了社会人口统计学、诊断(临床、生化和影像学)和治疗数据,并使用社会科学统计软件包 (SPSS) 进行组织和分析。

结果

382 名患者中,321 名接受保守治疗,61 名接受肾脏替代治疗。参与者的平均年龄为 47.71±16.10 岁。双足肿胀(16.8%)、疲劳(10.4%)和面部肿胀(9.2%)是主要的临床特征。慢性肾小球肾炎(31.4%)、高血压(30.3%)和糖尿病肾病(28.2%)是最常见的诱发因素。硝苯地平(82.0%)、比索洛尔(32.8%)、阿司匹林(19.7%)、雷尼替丁(26.2%)、二甲双胍(13.1%)和速尿(78.7%)是 RRT 患者比保守治疗患者更常用的药物。与 RRT 患者相比,接受保守治疗的患者更常使用厄贝沙坦/赖诺普利(57.9%)和碳酸氢钠(52.0%)。与 RRT 患者相比,接受保守治疗的患者舒张压(DBP)(p=0.047)、尿毒症性胃炎(p=0.007)、贫血、尿毒症、血尿和高钾血症(p<0.001)更为常见,而 RRT 患者的皮质髓质分化更好(38.1%比 27.7%,p<0.001),回声均匀(15.0%比 11.6%,p=0.005)。年龄、性别、职业和病程与选择保守治疗有显著相关性。

结论

接受保守治疗的患者的临床结局比接受 RRT 治疗的患者差。应尽早向肾病专家转诊,并提供补贴的肾脏替代治疗。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfac/9608926/42cefeeb6c35/12882_2022_2951_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfac/9608926/42cefeeb6c35/12882_2022_2951_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bfac/9608926/42cefeeb6c35/12882_2022_2951_Fig1_HTML.jpg

相似文献

1
Conservative therapy is associated with worse clinical features and biochemical derangements than renal replacement therapy: a retrospective study in Kumasi, Ghana.与肾脏替代疗法相比,保守治疗与更差的临床特征和生化紊乱相关:加纳库马西的一项回顾性研究。
BMC Nephrol. 2022 Oct 26;23(1):343. doi: 10.1186/s12882-022-02951-z.
2
Demographic, diagnostic and therapeutic characteristics of autosomal dominant polycystic kidney disease in Ghana.加纳常染色体显性遗传性多囊肾病的人口统计学、诊断和治疗特征。
BMC Nephrol. 2021 Apr 28;22(1):156. doi: 10.1186/s12882-021-02336-8.
3
Decision-making experiences of patients with end-stage kidney disease (ESKD) regarding treatment in Ghana: a qualitative study.加纳终末期肾病患者治疗决策体验的定性研究。
BMC Nephrol. 2018 Dec 19;19(1):371. doi: 10.1186/s12882-018-1175-z.
4
Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.欧洲接受肾脏替代治疗的系统性硬化症(硬皮病)患者的特征和结局:来自 ERA-EDTA 登记处的结果。
Am J Kidney Dis. 2019 Feb;73(2):184-193. doi: 10.1053/j.ajkd.2018.05.016. Epub 2018 Aug 16.
5
Influence of a pre-dialysis education programme (PDEP) on the mode of renal replacement therapy.透析前教育计划(PDEP)对肾脏替代治疗模式的影响。
Nephrol Dial Transplant. 2005 Sep;20(9):1842-7. doi: 10.1093/ndt/gfh905. Epub 2005 May 26.
6
Conservative care in Europe--nephrologists' experience with the decision not to start renal replacement therapy.欧洲的保守治疗——肾科医生在决定不开始肾脏替代治疗方面的经验。
Nephrol Dial Transplant. 2013 Oct;28(10):2604-12. doi: 10.1093/ndt/gft287. Epub 2013 Sep 7.
7
ESRD from autosomal dominant polycystic kidney disease in the United States, 2001-2010.2001 - 2010年美国常染色体显性多囊肾病导致的终末期肾病
Am J Kidney Dis. 2014 Oct;64(4):592-9. doi: 10.1053/j.ajkd.2014.05.020. Epub 2014 Aug 16.
8
Early referral to a nephrologist is associated with better outcomes in type 2 diabetes patients with end-stage renal disease.早期转诊至肾病专家处与2型糖尿病终末期肾病患者更好的预后相关。
Diabetes Metab. 2004 Feb;30(1):67-74. doi: 10.1016/s1262-3636(07)70091-5.
9
Factors influencing the timing of initiation of renal replacement therapy and choice of modality in children with end-stage kidney disease.影响终末期肾病儿童开始肾脏替代治疗时机和方式选择的因素。
Pediatr Nephrol. 2020 Jan;35(1):145-151. doi: 10.1007/s00467-019-04391-8. Epub 2019 Oct 25.
10
Trends in renal replacement therapy in Turkey, 1996-2008.土耳其的肾脏替代疗法趋势,1996-2008 年。
Am J Kidney Dis. 2011 Mar;57(3):456-65. doi: 10.1053/j.ajkd.2010.12.007.

引用本文的文献

1
Exploring Nurses' Supportive Care Practices for Managing Patients with Chronic Kidney Disease (CKD) in a Tertiary Care Facility in Ghana.探索加纳一家三级医疗机构中护士对慢性肾脏病(CKD)患者的支持性护理实践。
SAGE Open Nurs. 2025 Jun 20;11:23779608251350750. doi: 10.1177/23779608251350750. eCollection 2025 Jan-Dec.

本文引用的文献

1
Detailed Review of Chronic Kidney Disease.慢性肾脏病详细综述
Kidney Dis (Basel). 2020 Mar;6(2):85-91. doi: 10.1159/000504622. Epub 2019 Dec 18.
2
Influence of gender and age on haemodialysis practices: a European multicentre analysis.性别和年龄对血液透析实践的影响:一项欧洲多中心分析。
Clin Kidney J. 2019 Jun 17;13(2):217-224. doi: 10.1093/ckj/sfz069. eCollection 2020 Apr.
3
ACE inhibitors and ARBs: Managing potassium and renal function.血管紧张素转换酶抑制剂和血管紧张素受体拮抗剂:血钾和肾功能管理。
Cleve Clin J Med. 2019 Sep;86(9):601-607. doi: 10.3949/ccjm.86a.18024.
4
2018 Korean Society of Hypertension Guidelines for the management of hypertension: part II-diagnosis and treatment of hypertension.2018年韩国高血压学会高血压管理指南:第二部分——高血压的诊断与治疗
Clin Hypertens. 2019 Aug 1;25:20. doi: 10.1186/s40885-019-0124-x. eCollection 2019.
5
Value-based evaluation of dialysis versus conservative care in older patients with advanced chronic kidney disease: a cohort study.老年晚期慢性肾脏病患者透析与保守治疗的基于价值的评估:一项队列研究
BMC Nephrol. 2018 Aug 16;19(1):205. doi: 10.1186/s12882-018-1004-4.
6
Hematuria as a risk factor for progression of chronic kidney disease and death: findings from the Chronic Renal Insufficiency Cohort (CRIC) Study.血尿作为慢性肾脏病进展和死亡的风险因素:来自慢性肾功能不全队列(CRIC)研究的结果。
BMC Nephrol. 2018 Jun 26;19(1):150. doi: 10.1186/s12882-018-0951-0.
7
Palliative Care Disincentives in CKD: Changing Policy to Improve CKD Care.终末期肾病中缓和医疗的抑制因素:改变政策以改善终末期肾病的护理。
Am J Kidney Dis. 2018 Jun;71(6):866-873. doi: 10.1053/j.ajkd.2017.12.017. Epub 2018 Mar 3.
8
A Summary of Worldwide National Activities in Chronic Kidney Disease (CKD) Testing.全球慢性肾脏病(CKD)检测国家活动总结
EJIFCC. 2017 Dec 19;28(4):302-314. eCollection 2017 Dec.
9
Palliative care for patients with end-stage renal disease: approach to treatment that aims to improve quality of life and relieve suffering for patients (and families) with chronic illnesses.终末期肾病患者的姑息治疗:旨在改善慢性病患者(及其家属)生活质量并减轻痛苦的治疗方法。
Clin Kidney J. 2017 Feb;10(1):68-73. doi: 10.1093/ckj/sfw105. Epub 2016 Dec 16.
10
Disease Trajectories Before ESRD: Implications for Clinical Management.终末期肾病前的疾病轨迹:对临床管理的启示
Semin Nephrol. 2017 Mar;37(2):132-143. doi: 10.1016/j.semnephrol.2016.12.003.